Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]

Yang X, Hou Z, Zhu K, et al. Cancer Manag Res. 2020;12:3163- 3173. The authors have advised there is an error with Figure 2 onpage 3170. The figure parts C-H do not match the descriptionin the figure caption or figure citations throughout thetext. The authors apologizefor this error. Read the origin...

Full description

Saved in:
Bibliographic Details
Published in:Cancer management and research 2020-06, Vol.12, p.4169-4170
Main Authors: Yang, XueJiao, Hou, ZhenYu, Zhu, KeYun, Zhang, Su, Gu, XiaoYing, Wang, ZhiWei, Mu, Han, Zhou, HongYuan, Chen, Ping, Zhu, XiaoLin, Cui, YunLong, Li, Qiang, Li, HuiKai, Zhang, Ti
Format: Article
Language:English
Subjects:
Cancer
Corrigendum
Drug therapy
hcc
htn
Hypertension
liver cancer
resistance
vegfr-2
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Yang X, Hou Z, Zhu K, et al. Cancer Manag Res. 2020;12:3163- 3173. The authors have advised there is an error with Figure 2 onpage 3170. The figure parts C-H do not match the descriptionin the figure caption or figure citations throughout thetext. The authors apologizefor this error. Read the original article
ISSN:1179-1322
1179-1322
DOI:10.2147/CMAR.S263933